Phylogenetic quantification of intra-tumour heterogeneity.

Abstract excerpt

Intra-tumour genetic heterogeneity is the result of ongoing evolutionary change within each cancer. The expansion of genetically distinct sub-clonal populations may explain the emergence of drug resistance, and if so, would have prognostic and predictive utility. However, methods for objectively quantifying tumour heterogeneity have been missing and are particularly difficult to establish in cancers where...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alleles
• Share to Biological Evolution
• Share to Cancer Genomics and Diagnostics